市场调查报告书
商品编码
1535230
气球鼻窦形成术系统市场:各市场区隔规模,占有率,法律规章,偿付,手术,2033年为止的预测Balloon Sinuplasty Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
球囊鼻窦成形术系统,也称为球囊扩张导管系统或鼻窦扩张系统,是一种利用球囊导管和充气装置来打开阻塞的鼻窦通道的装置。
慢性鼻窦炎 (CRS) 是一种持续超过 12 週的鼻窦和鼻腔发炎性疾病。慢性鼻窦炎是一组具有共同临床和病理特征的异质性疾病。球囊鼻窦成形术正迅速成为慢性或严重鼻窦炎的首选手术,这些鼻窦炎对其他药物治疗(如鼻减充血剂和冲洗剂、抗生素以及鼻和口服皮质类固醇)没有反应,并且已被广泛应用。
本报告提供全球气球鼻窦形成术系统市场相关资料详细考察,提供市场上竞争情形,SWOT分析,到2033年为止的市场预测,地区,各国的趋势等资讯。
Balloon Sinuplasty Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within ENT Devices therapeutic area.
Balloon sinuplasty systems, also known as balloon dilation catheter systems or sinus dilation systems, are devices which are used to open blocked sinus passages using balloon catheters & inflation devices.
Chronic rhinosinusitis (CRS) is an inflammatory disorder of paranasal sinuses and lining of the nasal passages that lasts 12 weeks or longer. It is a heterogenous group of disorders that share certain clinical and pathologic features. Balloon sinuplasty is quickly becoming the surgery of choice for chronic or severe sinusitis that does not respond to other medical therapies, such as nasal decongestant medications and rinses, antibiotics, and nasal and oral corticosteroids.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Balloon Sinuplasty Systems and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Acclarent Inc, Medtronic Plc, Entellus Medical Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -